Nasal polyps
Jun 27, 2019
Sanifit nets USD 80.9 M; FDA approves Dupixent for CRS; AbbVie buys Allergan
Sanifit raises USD 80.9 M to advance Calciphylaxis Pipeline Sanifit, a clinical-stage biopharmaceutical company, has raised USD 80.9 million ( €72.2 million ) in total private fundraising. The financing mainly consisted led by Spain’s Caixa Capital Risc, along with many new investors, including Columbus Venture ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
